IT1127225B - 5-(2-imidazolin-2-il)-aminopirimidine sostituite e processo per la loro preparazione - Google Patents
5-(2-imidazolin-2-il)-aminopirimidine sostituite e processo per la loro preparazioneInfo
- Publication number
- IT1127225B IT1127225B IT27284/79A IT2728479A IT1127225B IT 1127225 B IT1127225 B IT 1127225B IT 27284/79 A IT27284/79 A IT 27284/79A IT 2728479 A IT2728479 A IT 2728479A IT 1127225 B IT1127225 B IT 1127225B
- Authority
- IT
- Italy
- Prior art keywords
- aminopyrimidines
- imidazolin
- replaced
- preparation
- replaced aminopyrimidines
- Prior art date
Links
- 150000005005 aminopyrimidines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/30—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2849537A DE2849537C2 (de) | 1978-11-15 | 1978-11-15 | Substituierte 5-(2-Imidazolin-2-yl)-aminopyrimidine, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
| DE19792937023 DE2937023A1 (de) | 1979-09-13 | 1979-09-13 | Neue substituierte 5-(2-imidazolin-2-yl)-aminopyrimidine und verfahren zu deren herstellung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IT7927284A0 IT7927284A0 (it) | 1979-11-14 |
| IT1127225B true IT1127225B (it) | 1986-05-21 |
Family
ID=25776489
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT27284/79A IT1127225B (it) | 1978-11-15 | 1979-11-14 | 5-(2-imidazolin-2-il)-aminopirimidine sostituite e processo per la loro preparazione |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4323570A (it) |
| AT (1) | AT374197B (it) |
| AU (1) | AU541305B1 (it) |
| CA (1) | CA1138454A (it) |
| CH (1) | CH642965A5 (it) |
| DK (1) | DK150142C (it) |
| ES (1) | ES486349A1 (it) |
| FR (1) | FR2441625A1 (it) |
| GB (1) | GB2039275B (it) |
| IT (1) | IT1127225B (it) |
| NL (2) | NL190553C (it) |
| SE (1) | SE440079B (it) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0139477A3 (en) * | 1983-09-23 | 1985-11-21 | Eli Lilly And Company | Process for preparing 5-substituted pyrimidines |
| DE3729299A1 (de) * | 1987-09-02 | 1989-03-23 | Beiersdorf Ag | Transdermales therapeutisches system |
| DE3739779A1 (de) * | 1987-11-24 | 1989-06-08 | Beiersdorf Ag | Pharmazeutische praeparate |
| DE3904795C2 (de) * | 1989-02-17 | 2000-10-12 | Lilly Pharma Produktion Gmbh & | Pharmazeutisches Präparat und dessen Verwendung |
| US5972948A (en) * | 1994-07-01 | 1999-10-26 | Solvay Pharmaceuticals Gmbh | Method of inhibiting hyperglycemia and pharmaceutical composition for use therein |
| DE4423177A1 (de) * | 1994-07-01 | 1996-01-04 | Kali Chemie Pharma Gmbh | Antihyperglykämisch wirksame Arzneimittel |
| WO1996026728A2 (en) * | 1995-02-28 | 1996-09-06 | Beiersdorf-Lilly Gmbh | Use of moxonidine for the treatment of atherosclerosis |
| DE19514579A1 (de) * | 1995-04-20 | 1996-10-24 | Boehringer Ingelheim Kg | Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz |
| US5658903A (en) * | 1995-06-07 | 1997-08-19 | Smithkline Beecham Corporation | Imidazole compounds, compositions and use |
| CA2182851A1 (en) * | 1995-08-15 | 1997-02-16 | August Masaru Watanabe | Method for treating substance abuse withdrawal |
| TR199802496T2 (xx) * | 1996-06-06 | 1999-02-22 | Eli Lilly And Company | Konjestif kalp yetmezli�ini tedavi i�in form�lasyon. |
| NO980546L (no) * | 1997-02-11 | 1998-08-12 | Lilly Co Eli | Farmas°ytiske midler |
| DE19722322A1 (de) * | 1997-05-28 | 1998-12-03 | Solvay Pharm Gmbh | Nephroprotektives Arzneimittel |
| CA2269971A1 (en) * | 1997-09-03 | 1999-03-11 | Trent Lee Abraham | Pyrimidine derivatives |
| DE19911371A1 (de) | 1999-03-15 | 2000-09-21 | Solvay Pharm Gmbh | Arzneimittel zur Behandlung von funktionellen Störungen und Erkrankungen der unteren Darmwege, insbesondere von damit einhergehenden abdominalen visceralen Schmerzen |
| AU2003257418A1 (en) * | 2002-06-19 | 2004-01-06 | Solvay Pharmaceuticals Gmbh | Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins |
| JP2009524619A (ja) * | 2006-01-27 | 2009-07-02 | エフ．ホフマン−ラ ロシュ アーゲー | Ｃｎｓ障害の処置のための２−イミダゾールの使用 |
| EP1873152B1 (en) * | 2006-06-26 | 2008-10-15 | Chemagis Ltd. | Novel purification process of moxonidine |
| EP1894926A1 (en) * | 2006-06-26 | 2008-03-05 | Chemagis Ltd. | Polymorphs of moxonidine and processes for preparation therefor |
| DE602006002738D1 (de) * | 2006-06-26 | 2008-10-23 | Chemagis Ltd | Verbessertes Verfahren zur Herstellung von Moxonidine |
| WO2008020425A1 (en) * | 2006-08-17 | 2008-02-21 | Chemagis Ltd. | Crystalline moxonidine comprising single tautomer and preparation process therefor |
| DE602006018139D1 (de) * | 2006-08-31 | 2010-12-23 | Chemagis Ltd | Verwendung der Monoxidinssalze zur Reinigung von Monoxidin |
| ATE546437T1 (de) * | 2006-10-19 | 2012-03-15 | Hoffmann La Roche | Aminomethyl-4-imidazole |
| RU2009112495A (ru) * | 2006-10-19 | 2010-11-27 | Ф. Хоффманн-Ля Рош Аг (Ch) | Аминометил-2-имидазолы со сродством к рецепторам, ассоциированным со следовыми аминами |
| KR101176700B1 (ko) * | 2006-11-02 | 2012-08-23 | 에프. 호프만-라 로슈 아게 | 미량 아민 결합된 수용체의 조절자로서 치환된 2-이미다졸 |
| CA2669112A1 (en) * | 2006-11-16 | 2008-05-22 | F. Hoffmann-La Roche Ag | Substituted 4-imidazoles |
| WO2008073125A1 (en) * | 2006-12-12 | 2008-06-19 | Chemagis Ltd. | Moxonidine analogs, preparation processes and uses therefor |
| JP2010513238A (ja) * | 2006-12-13 | 2010-04-30 | エフ．ホフマン−ラ ロシュ アーゲー | 微量アミン関連受容体（ｔａａｒ）に対するリガンドとしての新規２−イミダゾール |
| US20080146523A1 (en) | 2006-12-18 | 2008-06-19 | Guido Galley | Imidazole derivatives |
| KR101275405B1 (ko) | 2007-02-02 | 2013-06-17 | 에프. 호프만-라 로슈 아게 | 중추 신경계 장애의 치료용 ｔａａｒ1 리간드로서 2-아미노옥사졸린 |
| KR101335845B1 (ko) * | 2007-02-15 | 2013-12-02 | 에프. 호프만-라 로슈 아게 | Ｔａａｒ1 리간드로서의 2-아미노옥사졸린 |
| WO2009003868A2 (en) | 2007-07-02 | 2009-01-08 | F. Hoffmann-La Roche Ag | 2 -imidazolines having a good affinity to the trace amine associated receptors (taars) |
| AU2008270444A1 (en) * | 2007-07-03 | 2009-01-08 | F. Hoffmann-La Roche Ag | 4-imidazolines and their use as antidepressants |
| EP2183216A1 (en) * | 2007-07-27 | 2010-05-12 | F. Hoffmann-Roche AG | 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as taar-ligands |
| WO2009016088A1 (en) * | 2007-08-02 | 2009-02-05 | F. Hoffmann-La Roche Ag | The use of benzamide derivatives for the treatment of cns disorders |
| CA2695331A1 (en) * | 2007-08-03 | 2009-02-12 | F. Hoffmann-La Roche Ag | Pyridinecarboxamide and benzamide derivatives as taar1 ligands |
| US8242153B2 (en) * | 2008-07-24 | 2012-08-14 | Hoffmann-La Roche Inc. | 4,5-dihydro-oxazol-2YL derivatives |
| PE20110215A1 (es) * | 2008-07-24 | 2011-03-31 | Hoffmann La Roche | Derivados de 4,5-dihidro-oxazol-2-ilo |
| US20100311798A1 (en) * | 2009-06-05 | 2010-12-09 | Decoret Guillaume | 2-aminooxazolines as taar1 ligands |
| US8354441B2 (en) * | 2009-11-11 | 2013-01-15 | Hoffmann-La Roche Inc. | Oxazoline derivatives |
| US9452980B2 (en) | 2009-12-22 | 2016-09-27 | Hoffmann-La Roche Inc. | Substituted benzamides |
| EP2586779A1 (en) | 2011-10-24 | 2013-05-01 | Hetero Research Foundation | Process for the preparation of moxonidine |
| DE102012215896A1 (de) | 2012-09-07 | 2014-03-13 | Wörwag Pharma GmbH & Co.KG | Moxonidinsynthese mit Hilfe organischer Basen |
| ES2608004T3 (es) | 2012-12-03 | 2017-04-05 | WÖRWAG PHARMA GmbH & Co. KG | Método mediante catálisis por transferencia de fase |
| EP2765131B1 (en) | 2013-02-08 | 2016-11-23 | Arevipharma GmbH | Process for the production of Moxonidine |
| EP2970214A1 (en) * | 2013-03-14 | 2016-01-20 | Farmak, A.S. | Improved process for the manufacture of moxonidine |
| EP2829540A1 (en) | 2013-07-26 | 2015-01-28 | Abbott Healthcare Products B.V. | Synthesis of substituted aminopyridines |
| US20160184387A1 (en) | 2013-08-09 | 2016-06-30 | Dominique Charmot | Compounds and methods for inhibiting phosphate transport |
| HUE050986T2 (hu) | 2016-03-17 | 2021-01-28 | Hoffmann La Roche | 5-etil-4-metil-pirazol-3-karboxamid származék, amely TAAR-agonista aktivitású |
| WO2022101435A1 (en) | 2020-11-12 | 2022-05-19 | 3Z Ehf | Novel treatments of attention deficit/hyperactivity disorder |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE754832A (fr) | 1969-08-14 | 1971-02-15 | Beecham Group Ltd | Iminazolines |
| GB1319840A (en) * | 1970-08-27 | 1973-06-13 | Beecham Group Ltd | Substituted 5-amino imidazoles |
| BE795636A (fr) * | 1972-02-19 | 1973-08-20 | Schering Ag | Nitroimidazolylpyrimidines, et leur procede de preparation |
| US4029792A (en) * | 1972-02-29 | 1977-06-14 | Pfizer Inc. | (2-Imidazolin-2-ylamino) substituted -quinoxalines and -quinazolines as antihypertensive agents |
| DE2220906A1 (de) * | 1972-04-28 | 1973-11-15 | Boehringer Sohn Ingelheim | Neue substituierte 2-phenylaminoimidazoline-(2), deren saeureadditionssalze sowie verfahren zu deren herstellung |
| BE503170A (it) * | 1975-09-02 |
-
1979
- 1979-11-07 US US06/092,134 patent/US4323570A/en not_active Expired - Lifetime
- 1979-11-08 NL NLAANVRAGE7908192,A patent/NL190553C/xx not_active IP Right Cessation
- 1979-11-14 SE SE7909392A patent/SE440079B/sv not_active IP Right Cessation
- 1979-11-14 IT IT27284/79A patent/IT1127225B/it active
- 1979-11-14 DK DK481879A patent/DK150142C/da not_active IP Right Cessation
- 1979-11-14 CA CA000339844A patent/CA1138454A/en not_active Expired
- 1979-11-14 GB GB7939460A patent/GB2039275B/en not_active Expired
- 1979-11-14 AT AT0727079A patent/AT374197B/de not_active IP Right Cessation
- 1979-11-14 ES ES486349A patent/ES486349A1/es not_active Expired
- 1979-11-15 CH CH1021679A patent/CH642965A5/de not_active IP Right Cessation
- 1979-11-15 AU AU52873/79A patent/AU541305B1/en not_active Expired
- 1979-11-15 FR FR7928169A patent/FR2441625A1/fr active Granted
-
1994
- 1994-06-27 NL NL940011C patent/NL940011I2/nl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SE440079B (sv) | 1985-07-15 |
| FR2441625A1 (fr) | 1980-06-13 |
| NL940011I1 (nl) | 1994-08-01 |
| NL940011I2 (nl) | 1998-05-06 |
| FR2441625B1 (it) | 1981-12-31 |
| DK150142B (da) | 1986-12-15 |
| SE7909392L (sv) | 1980-05-16 |
| CH642965A5 (de) | 1984-05-15 |
| CA1138454A (en) | 1982-12-28 |
| ES486349A1 (es) | 1980-06-16 |
| ATA727079A (de) | 1983-08-15 |
| GB2039275A (en) | 1980-08-06 |
| US4323570A (en) | 1982-04-06 |
| AU541305B1 (en) | 1985-01-03 |
| GB2039275B (en) | 1982-11-17 |
| AT374197B (de) | 1984-03-26 |
| DK481879A (da) | 1980-05-16 |
| NL190553B (nl) | 1993-11-16 |
| NL190553C (nl) | 1994-04-18 |
| NL7908192A (nl) | 1980-05-19 |
| DK150142C (da) | 1987-06-01 |
| IT7927284A0 (it) | 1979-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT1127225B (it) | 5-(2-imidazolin-2-il)-aminopirimidine sostituite e processo per la loro preparazione | |
| IT1112761B (it) | Processo per la formazione di peci in neomesofase | |
| IT1097652B (it) | 17-alchilcarbonati di corticosteroidi e processo per la loro preparazione | |
| IT1094039B (it) | Processo per la preparazione di 2,2,6,6-tetrametil-4-piperidone | |
| IT1096492B (it) | Solfamoil-arilchetoni e processo per la loro preparazione | |
| IT7949570A0 (it) | Coloranti catiolici e procedimento per la loro produzione ed applicazione | |
| IT1098396B (it) | Fenileteri eterociclici e processo per la loro preparazione | |
| BR7904057A (pt) | Processo fisico-bioquimico | |
| IT1098864B (it) | Processo per la preparazione di nitroimidazoli | |
| IT7927410A0 (it) | Composizione e processo. | |
| IT8021089A0 (it) | Furani arilsostituiti e processo per la loro preparazione. | |
| IT1094608B (it) | Benzenesolfoniluree e processo per la loro preparazione | |
| IT1101647B (it) | Composti 1.8-naftiridinici e processo per la loro preparazione | |
| IT7822440A0 (it) | N-fenilformamidossime sostituite e processo per la loro preparazione. | |
| IT1126432B (it) | Esaidro-2,6-metano-3-benzazocine e processo di loro preparazione | |
| BR7907758A (pt) | Processo de preparacao de 2,3-dihidro-2,2-dimetil-7-hidroxi-benzofurano | |
| IT1101646B (it) | 4-carbeiossi-carbonilamino-pirimidine e processo per la loro preparazione | |
| BR7900730A (pt) | Composicao de derivados de 1,4-benzoazina e processo de sua preparacao | |
| IT1075815B (it) | Mezzi di rivestimento e processo per la loro preparazione | |
| IT1098203B (it) | Cefalosporine e processo per la loro preparazione | |
| IT1096405B (it) | Composti azotati eterociclici e processo per la loro preparazione | |
| IT1141073B (it) | Processo per la preparazione di 3-(4-piridinil)-2-cicloesen-1-onossina | |
| IT1193345B (it) | Nuovi 3-idrossi-1,4-benzodiazepin-2-oni e processo per la loro preparazione | |
| IT7920652A0 (it) | Processo per la preparazione di ciclopropancarbaldeide. | |
| BR7902122A (pt) | Processo integrado de amoniacoureia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19971126 |